Lupin Limited — Linezolid Exporter Profile
Indian Pharmaceutical Exporter · #3 for Linezolid · $2.3M export value · DGFT Verified
Lupin Limited is the #3 Indian exporter of Linezolid with $2.3M in export value and 46 verified shipments. Lupin Limited holds a 6.1% market share in Linezolid exports across 9 countries. The company exports 38 pharmaceutical products worth $271.4M across 19 therapeutic categories.
Lupin Limited — Linezolid Export Profile: Buyers & Destinations
Where Does Lupin Limited Export Linezolid?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $1.4M | 33 | 80.9% |
| PHILIPPINES | $100.0K | 2 | 5.6% |
| COLOMBIA | $50.0K | 1 | 2.8% |
| INDONESIA | $44.3K | 1 | 2.5% |
| PAKISTAN | $40.3K | 1 | 2.3% |
| FRANCE | $35.9K | 3 | 2.0% |
| THAILAND | $33.2K | 2 | 1.9% |
| MYANMAR | $19.3K | 2 | 1.1% |
| CONGO | $18.7K | 1 | 1.0% |
Lupin Limited exports Linezolid to 9 countries. The largest destination is NETHERLANDS accounting for 80.9% of Lupin Limited's Linezolid shipments, followed by PHILIPPINES (5.6%) and COLOMBIA (2.8%). These destinations reflect Lupin Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Linezolid from Lupin Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| I SOLUTIONS | NETHERLANDS | $334.7K | 7 |
| GDF TILBURG D102TC | NETHERLANDS | $300.0K | 6 |
| I+SOLUTIONS | NETHERLANDS | $290.9K | 6 |
| GDF TILBURG SRS D102TC | NETHERLANDS | $144.9K | 3 |
| GDF TILBURG | NETHERLANDS | $100.1K | 3 |
| DEPARTMENT OF HEALTH | PHILIPPINES | $100.0K | 2 |
| I+ SOLUTIONS | NETHERLANDS | $93.4K | 2 |
| GDF TILBURG SRS D102TC HAYA VAN | NETHERLANDS | $83.1K | 2 |
| GDF TILBURG SRS | NETHERLANDS | $50.0K | 1 |
| MINISTERIO DE SALUD Y PROTECCION SO | COLOMBIA | $50.0K | 1 |
Lupin Limited supplies Linezolid to 18 buyers globally. The largest buyer is I SOLUTIONS (NETHERLANDS), followed by GDF TILBURG D102TC (NETHERLANDS) and I+SOLUTIONS (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Linezolid Export Value and How Much Does Lupin Limited Contribute?
India exported $21.3M worth of Linezolid through 1,427 shipments from 234 suppliers to 104 countries, serving 420 buyers globally. Lupin Limited contributes $2.3M to this total, accounting for 6.1% of India's Linezolid exports. Lupin Limited ships Linezolid to 9 countries through 18 buyers.
What Is the Average Shipment Value for Lupin Limited's Linezolid Exports?
Lupin Limited's average Linezolid shipment value is $50.0K per consignment, based on 46 shipments totaling $2.3M. The largest destination is NETHERLANDS (80.9% of Lupin Limited's Linezolid exports).
How Does Lupin Limited Compare to Other Indian Linezolid Exporters?
Lupin Limited ranks #3 among 234 Indian Linezolid exporters with a 6.1% market share. The top 3 exporters are ALKEM LABORATORIES LIMITED ($4.3M), EUGIA PHARMA SPECIALITIES LIMITED ($3.8M), MACLEODS PHARMACEUTICALS LTD ($3.6M). Lupin Limited processed 46 shipments to 9 destination countries.
What Linezolid Formulations Does Lupin Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| LINEZOLID TABLETS 600MG GDF 10X10 LINEZO | $445.0K | 10 |
| LINEZOLID TABLETS 600MG GDF 10X10 LINEZOLID TABLETS 600 MG | $150.0K | 3 |
| LINEZOLID TABLETS 600MG GDF 10X10BATCHNO. J304381,M.DT.08/08/23,E.DT:31/07/26,BATCH NO. J304382,M.DT.10/08/23,E.DT:31/ | $100.0K | 2 |
| LINEZOLID TABLETS 600MG GDF 10X10BATCHNO. J304529 MANUFACTURING DT.28/08/23 Exp DT. 31/07/26 J304530 MANUFACTURING DT. 30/08/23 EXP DT. | $100.0K | 2 |
| LINEZOLID TABLETS USP 600MG 10X10 LINEZOLID TABLETS USP 600MG (5,200 BOX) | $100.0K | 2 |
| LINEZOLID TABLETS 600MG 10X10 LINEZOLID | $50.0K | 1 |
| LINEZOLID TABLETS 600MG GDF 10X10BATCHNO. J304385J304386J304387 MANUFACTURING .DT.16/08/23 EXP.DT. 31/07/26BATCH NO.J304388 | $50.0K | 1 |
| LINEZOLID TABLETS 600MG GDF 10X10 LINEZOLID TABLETS 600 MG (3,900.000 BOX) | $50.0K | 1 |
| LINEZOLID TABLETS 600MG GDF 10X10 (J304993,J304994, MFG DT.28/11/23,EXP DT.30/11/26, J305169,J305170 ,J305171 *** | $50.0K | 1 |
| LINEZOLID TABLETS 600MG GDF 10X10 (10400BOX) | $50.0K | 1 |
Lupin Limited exports 27 distinct Linezolid formulations including tablets, capsules, syrups, and combination drugs. The top formulation is LINEZOLID TABLETS 600MG GDF 10X10 LINEZO with 10 shipments worth $445.0K.
How Does Lupin Limited Compare to Nearest Linezolid Exporters?
Exporters ranked immediately above and below #3 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | EUGIA PHARMA SPECIALITIES LIMITED | $3.8M | 91 | 3 | $41.7K |
| 1 | MACLEODS PHARMACEUTICALS LTD | $3.6M | 73 | 20 | $50.0K |
| 3 | LUPIN LIMITED ★ | $2.3M | 46 | 9 | $50.0K |
| 8 | ACULIFE HEALTHCARE PRIVATE LIMITED | $1.5M | 42 | 8 | $34.6K |
| 9 | MICRO LABS LIMITED | $1.3M | 25 | 7 | $50.0K |
Lupin Limited ranks #3 among 234 Indian Linezolid exporters. Average shipment value of $50.0K compared to the market average of $91.1K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and MACLEODS PHARMACEUTICALS LTD.
Which Indian Ports Ship Linezolid Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 219 | 15.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 165 | 11.6% |
| DELHI AIR | 151 | 10.6% |
| DELHI AIR CARGO ACC (INDEL4) | 140 | 9.8% |
| NHAVA SHEVA SEA (INNSA1) | 95 | 6.7% |
| JNPT/ NHAVA SHEVA SEA | 44 | 3.1% |
| Bombay Air | 43 | 3.0% |
| Bombay Air Cargo | 30 | 2.1% |
What Other Advanced Antibiotics Products Does Lupin Limited Export?
Lupin Limited also exports these advanced antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Lupin Limited's Linezolid Exports
Lupin's export operations are influenced by various geopolitical factors. The ongoing Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, thereby escalating shipping costs for Indian exporters. (sgexports.odoo.com) Additionally, the 2025 United States–India diplomatic and trade crisis resulted in the U.S. imposing a 50% tariff on Indian exports, significantly affecting the competitiveness of Indian pharmaceutical products in the U.S. market. (en.wikipedia.org)
Conversely, the European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) poses compliance challenges for Indian exporters, including Lupin, necessitating adherence to stringent carbon reporting requirements. However, the EU's focus on reducing dependency on Chinese pharmaceutical imports presents an opportunity for Indian companies to capture a larger share of the European market.
Lupin Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Lupin's global operations. In February 2025, the U.S. FDA completed a Pre-Approval Inspection at Lupin's Somerset, New Jersey facility with zero observations, reflecting the company's commitment to compliance and quality. (lupin.com) However, the evolving regulatory landscape, including the EU's falsified medicines directive and the U.S. FDA's increasing scrutiny, necessitates continuous investment in quality assurance and regulatory compliance to ensure uninterrupted market access.
About Lupin Limited
Lupin Limited exports 38 products worth $271.4M. Beyond Linezolid, top products include Isoniazid, Cephalexin, Simvastatin, Rifampicin, Amlodipine. View the complete Lupin Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Linezolid — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Linezolid shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Lupin Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 46 individual customs records matching Lupin Limited exporting Linezolid, covering 27 formulations to 9 countries via 18 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 420+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Linezolid Export Data from Lupin Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lupin Limited's Linezolid exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lupin Limited
Full Company Profile →
38 products · $271.4M total trade · 19 categories
Linezolid Stats
Company Overview
Top Products by Lupin Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Lupin Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Linezolid. For current shipment-level data, contact TransData Nexus.